Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Lauper

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Revue Medicale Suisse|January 25, 2024
Kim Lauper
Revue Medicale Suisse|March 11, 2026
[Janus kinase inhibitors or biological therapies in rheumatoid arthritis?]Kim Lauper
ARP Rheumatology|April 2, 2025
From forgotten to frontline: the new era of crystal diseases?Nils Bürgisser, Kim Lauper
Revue Medicale Suisse|March 14, 2020
[Small molecules treatment in rheumatoid arthritis]Aurore Verdon, Kim Lauper
Joint Bone Spine|March 31, 2020
Predictive factors of treatment persistence in rheumatoid arthritisKim Lauper, Axel Finckh
Revue Medicale Suisse|March 13, 2025
[Current challenges in the management of crystal induced arthritis]Mio Gobet, Kim Lauper
Seminars in Immunopathology|April 30, 2017
Cardiovascular risk in patients with rheumatoid arthritisKim Lauper, Cem Gabay
Revue Medicale Suisse|March 15, 2023
[Rheumatoid arthritis flares]Edouard Chaix, Kim Lauper
Expert Review of Clinical Immunology|September 16, 2021
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studiesKim Lauper, Kimme L Hyrich
Revue Medicale Suisse|March 20, 2022
[Vaccine prevention in patients with rheumatic diseases]Axel Finckh, Gilles Eperon, Kim Lauper
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Revue Medicale Suisse|January 25, 2024
Kim Lauper
Revue Medicale Suisse|March 11, 2026
[Janus kinase inhibitors or biological therapies in rheumatoid arthritis?]Kim Lauper
ARP Rheumatology|April 2, 2025
From forgotten to frontline: the new era of crystal diseases?Nils Bürgisser, Kim Lauper
Revue Medicale Suisse|March 14, 2020
[Small molecules treatment in rheumatoid arthritis]Aurore Verdon, Kim Lauper
Joint Bone Spine|March 31, 2020
Predictive factors of treatment persistence in rheumatoid arthritisKim Lauper, Axel Finckh
Revue Medicale Suisse|March 13, 2025
[Current challenges in the management of crystal induced arthritis]Mio Gobet, Kim Lauper
Seminars in Immunopathology|April 30, 2017
Cardiovascular risk in patients with rheumatoid arthritisKim Lauper, Cem Gabay
Revue Medicale Suisse|March 15, 2023
[Rheumatoid arthritis flares]Edouard Chaix, Kim Lauper
Expert Review of Clinical Immunology|September 16, 2021
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studiesKim Lauper, Kimme L Hyrich
Revue Medicale Suisse|March 20, 2022
[Vaccine prevention in patients with rheumatic diseases]Axel Finckh, Gilles Eperon, Kim Lauper
Pageof 7